Orange Book product · Brand (NDA)
DESONIDE
DESONIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
DESONIDE
Strength
0.05%
Dosage form
CREAM
Route
TOPICAL
TE code
Not listed
Application
NDA 017010
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2006DESONATEBrand (NDA)
NDA 021844 · LEO PHARMA AS
- 2006VERDESOBrand (NDA)
NDA 021978 · GENUS
- 1984DESOWENBrand (NDA)
NDA 019048 · GALDERMA LABS LP
- —DESONIDEBrand (NDA)
NDA 017426 · PADAGIS US
- 2022DESONIDEGeneric (ANDA)
ANDA 214396 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 213632 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 202470 · SENORES PHARMS
- 2019DESONIDEGeneric (ANDA)
ANDA 210198 · CADILA
- 2019DESONIDEGeneric (ANDA)
ANDA 212473 · ALEMBIC
- 2019DESONIDEGeneric (ANDA)
ANDA 212002 · PAI HOLDINGS PHARM
- 2019DESONIDEGeneric (ANDA)
ANDA 210998 · ENCUBE ETHICALS
- 2017DESONIDEGeneric (ANDA)
ANDA 207855 · ENCUBE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
